Daily Archives: March 28, 2017

BRCA Testing Has Skyrocketed, but Misses High-Risk Women

Although there has been a huge increase in BRCA mutation testing during the past decade, current guidelines and clinical practice do not include many women who are at high risk. Medscape Medical News …read more

FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

The U.S. Food and Drug Administration has approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian… …read more